Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.

Biotechnology

Aviceda Therapeutics

Mohamed A. Genead

Director, Financial Planning & Analysis (fp&a)

Mike Guo

Sunny Christian

Amitkumar Lad

David Callanan

Derek Kunimoto

Tarek S. Hassan

Anitha Krishnan

Michael Tolentino

Scientific and Clinical Advisors

Leadership Team

Research and Development

Technology and Quality Management

Teams at Aviceda Therapeutics

Scientific and Clinical Advisors

Leadership Team

Research and Development

Technology and Quality Management